PubRank

Zhi Dai

Author PubWeight™ 55.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011 3.80
2 Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res 2008 1.85
3 Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 2011 1.81
4 Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma. Cancer 2009 1.54
5 Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2011 1.46
6 Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 2005 1.33
7 CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma. Hepatology 2010 1.32
8 Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 2012 1.31
9 Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clin Cancer Res 2011 1.24
10 CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. Clin Cancer Res 2009 1.22
11 IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Mol Cancer 2011 1.19
12 MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression. Carcinogenesis 2013 1.19
13 Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion. Cancer Sci 2007 1.08
14 Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. Oncologist 2008 1.08
15 Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients. Int J Cancer 2014 1.07
16 Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma. Int J Cancer 2012 1.07
17 Activation of PI3K/AKT and MAPK pathway through a PDGFRβ-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma. PLoS One 2012 1.05
18 Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma. Hepatology 2009 1.00
19 Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Autophagy 2013 0.98
20 The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy. Tumour Biol 2015 0.98
21 An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2011 0.96
22 Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol 2005 0.93
23 Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. Cancer 2010 0.93
24 Plasma microRNA, a potential biomarker for acute rejection after liver transplantation. Transplantation 2013 0.90
25 CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. Carcinogenesis 2013 0.90
26 Sorafenib delays recurrence and metastasis after liver transplantation in a rat model of hepatocellular carcinoma with high expression of phosphorylated extracellular signal-regulated kinase. Liver Transpl 2013 0.89
27 Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma. PLoS One 2011 0.89
28 Proteome analysis of aflatoxin B1-induced hepatocarcinogenesis in tree shrew (Tupaia belangeri chinensis) and functional identification of candidate protein peroxiredoxin II. Proteomics 2008 0.89
29 Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma. Clin Cancer Res 2013 0.88
30 Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification. J Cancer Res Clin Oncol 2007 0.87
31 Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy. Biomark Res 2013 0.87
32 High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads. Ann Surg Oncol 2014 0.87
33 High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma. J Exp Clin Cancer Res 2014 0.86
34 Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection. PLoS One 2012 0.86
35 Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing. Hepatology 2014 0.85
36 Genetic polymorphism of the kinesin-like protein KIF1B gene and the risk of hepatocellular carcinoma. PLoS One 2013 0.85
37 Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma. Medicine (Baltimore) 2015 0.84
38 Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis. PLoS One 2013 0.84
39 CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma. J Pathol 2014 0.83
40 Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro. Proteomics 2006 0.83
41 T2* MRI of minimal hepatic encephalopathy and cognitive correlates in vivo. J Magn Reson Imaging 2012 0.82
42 Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation. PLoS One 2011 0.80
43 An investigation of the effect of sorafenib on tumour growth and recurrence after liver cancer resection in nude mice independent of phosphorylated extracellular signal-regulated kinase levels. Expert Opin Investig Drugs 2011 0.80
44 Prognostic indicators for tumor recurrence after liver transplantation in hepatocellular carcinoma and related molecular targeted therapy. Oncology 2011 0.80
45 Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection. J Cancer Res Clin Oncol 2010 0.80
46 Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma. Int J Cancer 2011 0.79
47 Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma. J Cancer Res Clin Oncol 2007 0.79
48 [Current advances in molecular targeted therapy of primary hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi 2009 0.77
49 DSA affinity glycoproteome of human liver tissue. Arch Biochem Biophys 2009 0.77
50 [The expression of peroxiredoxin II in hepatocellular carcinoma and its significance]. Zhonghua Gan Zang Bing Za Zhi 2007 0.77
51 Expression of hemopexin in acute rejection of rat liver allograft identified by serum proteomic analysis. Shock 2014 0.76
52 Molecular markers and hepatocellular carcinoma: lending a helping hand in liver transplantation? Expert Rev Gastroenterol Hepatol 2009 0.76
53 Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth. Expert Opin Investig Drugs 2009 0.76
54 [Proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma tissues]. Zhonghua Gan Zang Bing Za Zhi 2005 0.75
55 Con A affinity glycoproteomics of normal human liver tissue. Sci China C Life Sci 2007 0.75
56 The dynamic changes of T-bet(+)/GATA-3(+) and RORgammat(+)/FOXP3(+) cells in recipient spleens and grafts after rat orthotopic liver transplantation. Transpl Immunol 2009 0.75
57 [Proteomic analysis of hepatitis B virus-infected human liver tissues]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2007 0.75
58 [Screening low molecular weight protein biomarkers relevant to portal vein tumor thrombi in serum of patients with hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi 2007 0.75
59 [Differential analysis of tyrosine-phosphorylated proteins in human hepatocellular carcinoma cell lines with different metastasis potentials]. Zhonghua Gan Zang Bing Za Zhi 2005 0.75
60 [Screening hepatocellular carcinoma autoantibodies by serological proteome analysis]. Zhonghua Gan Zang Bing Za Zhi 2005 0.75
61 [The biological function of peroxiredoxin II on Hep3B cells and its underlying mechanism]. Zhonghua Gan Zang Bing Za Zhi 2008 0.75
62 [The role of beta irradiation on neointimal formation and apoptosis in vein grafts model]. Zhonghua Wai Ke Za Zhi 2002 0.75
63 Multifunctional Micellar Nanocarriers for Tumor-Targeted Delivery of Hydrophobic Drugs. J Biomed Nanotechnol 2016 0.75
64 Driving forces for the mutual conversions between phenothiazines and their various reaction intermediates in acetonitrile. J Phys Chem B 2008 0.75